Cargando…

PKCδ Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage

Neuroblastoma is a type of pediatric cancer. The sensitivity of neuroblastoma (NB) cancer cells to chemotherapy and radiation is inhibited by the presence of antioxidants, such as glutathione (GSH), which is crucial in counteracting the endogenous production of reactive oxygen species (ROS). We have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marengo, Barbara, De Ciucis, Chiara, Ricciarelli, Roberta, Passalacqua, Mario, Nitti, Mariapaola, Zingg, Jean-Marc, Marinari, Umberto M., Pronzato, Maria A., Domenicotti, Cinzia
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034714/ https://www.ncbi.nlm.nih.gov/pubmed/21326872 http://dx.doi.org/10.1371/journal.pone.0014661

Ejemplares similares

p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment
por: Marengo, B, et al.
Publicado: (2013)

Role of Glutathione in Cancer Progression and Chemoresistance
por: Traverso, Nicola, et al.
Publicado: (2013)

Protein Kinase C: An Attractive Target for Cancer Therapy
por: Marengo, Barbara, et al.
Publicado: (2011)

Glutathione Depletion by L-Buthionine-S,R-Sulfoximine Induces Apoptosis of Cardiomyocytes through Activation of PKC-δ
por: Kim, Young-Ae, et al.
Publicado: (2013)

PKCα Inhibition as a Strategy to Sensitize Neuroblastoma Stem Cells to Etoposide by Stimulating Ferroptosis
por: Monteleone, Lorenzo, et al.
Publicado: (2021)

Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
por: Marengo, Barbara, et al.
Publicado: (2016)

Hormesis and Oxidative Distress: Pathophysiology of Reactive Oxygen Species and the Open Question of Antioxidant Modulation and Supplementation
por: Nitti, Mariapaola, et al.
Publicado: (2022)

Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
por: Lee, F. Y., et al.
Publicado: (1987)

l-Buthionine Sulfoximine Detection and Quantification in Polyurea Dendrimer Nanoformulations
por: Mota, Pedro, et al.
Publicado: (2019)

Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma
por: Colla, Renata, et al.
Publicado: (2016)

Effects of Buthionine Sulfoximine Treatment on Cellular Glutathione Levels and Cytotoxicities of Cisplatin, Carboplatin and Radiation in Human Stomach and Ovarian Cancer Cell Lines(*): – Glutathione, Buthionine Sulfoximine, Cytotoxicity –
por: Lee, Kyung Shik, et al.
Publicado: (1992)

Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine
por: Du, Michael, et al.
Publicado: (2016)

Polyester-Based Dendrimer Nanoparticles Combined with Etoposide Have an Improved Cytotoxic and Pro-Oxidant Effect on Human Neuroblastoma Cells
por: Alfei, Silvana, et al.
Publicado: (2020)

Synthesis of Polystyrene-Based Cationic Nanomaterials with Pro-Oxidant Cytotoxic Activity on Etoposide-Resistant Neuroblastoma Cells
por: Alfei, Silvana, et al.
Publicado: (2021)

Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow.
por: Ono, K., et al.
Publicado: (1986)

In vivo production of different chloroform metabolites: effect of phenobarbital and buthionine sulfoximine pretreatment.
por: Gemma, S, et al.
Publicado: (1994)

The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO)
por: Chen, Jun, et al.
Publicado: (2005)

Differentiation impairs Bach1 dependent HO-1 activation and increases sensitivity to oxidative stress in SH-SY5Y neuroblastoma cells
por: Piras, Sabrina, et al.
Publicado: (2017)

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
por: Lee, Minjong, et al.
Publicado: (2017)

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S, et al.
Publicado: (2008)

Enhancement of Antitumor Activity of Cisplatin on Human Gastric Cancer Cells in vitro and in vivo by Buthionine Sulfoximine
por: Saikawa, Yoshiro, et al.
Publicado: (1993)

Protective Effect of Tempol on Buthionine Sulfoximine-Induced Mitochondrial Impairment in Hippocampal Derived HT22 Cells
por: Salvi, Ankita, et al.
Publicado: (2016)

The effects of buthionine sulfoximine treatment on diaphragm contractility and SERCA pump function in adult and middle aged rats
por: Smith, Ian C, et al.
Publicado: (2015)

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S., et al.
Publicado: (2018)

The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
por: Tagde, A, et al.
Publicado: (2014)

Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine Sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance
por: Cruz, Adriana, et al.
Publicado: (2020)

Multidrug Resistance-Associated Protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine Sulfoximine
por: Akan, Ilhan, et al.
Publicado: (2005)

Adenosine Improves Mitochondrial Function and Biogenesis in Friedreich’s Ataxia Fibroblasts Following L-Buthionine Sulfoximine-Induced Oxidative Stress
por: Lew, Sze Yuen, et al.
Publicado: (2023)

Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib
por: Furfaro, A. L., et al.
Publicado: (2016)

Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2020)

Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2023)

microRNA-494 Favors HO-1 Expression in Neuroblastoma Cells Exposed to Oxidative Stress in a Bach1-Independent Way
por: Piras, Sabrina, et al.
Publicado: (2018)

Synergistic Apoptosis of CML Cells by Buthionine Sulfoximine and Hydroxychavicol Correlates with Activation of AIF and GSH-ROS-JNK-ERK-iNOS Pathway
por: Chowdhury, Avik Acharya, et al.
Publicado: (2013)

Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination
por: Rao, Zhiping, et al.
Publicado: (2023)

RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage
por: Piras, S., et al.
Publicado: (2016)

Heme Oxygenase 1 in the Nervous System: Does It Favor Neuronal Cell Survival or Induce Neurodegeneration?
por: Nitti, Mariapaola, et al.
Publicado: (2018)

HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation
por: Nitti, Mariapaola, et al.
Publicado: (2017)

Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells
por: Alfei, Silvana, et al.
Publicado: (2020)

The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance
por: Furfaro, A. L., et al.
Publicado: (2016)

BIM(EL) is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine
por: Tanaka, Yukie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i95salreqnk2bovpsc48a4d2n3